Exact peptide identities attached to retained registry observations carrying this condition label.
Official registry condition
Membranoproliferative Glomerulonephritis peptide trials
3 selected ClinicalTrials.gov records carrying the official condition label Membranoproliferative Glomerulonephritis. The label is copied from each retained registry version and does not imply that PeptideScanner has verified a diagnosis, treatment relationship, or study result.
3 selected records.
1 profiles.
2026–2026 in selected records.
Indication intelligence
Selected evidence landscape
Phase labels copied from the retained ClinicalTrials.gov versions.
Overall statuses at each retained observation, not necessarily current today.
Across the connected peptide profiles, PeptideScanner also carries 25 selected PubMed records and 2 selected Drugs@FDA applications. Those records are profile context only; PeptideScanner does not claim they concern Membranoproliferative Glomerulonephritis unless their own cited source says so.
Collection change ledger
Recently changed records on this condition hub
These events come only from the exact registry records shown on this page. The condition label does not establish a diagnosis, treatment relationship, or scientific agreement.
ClinicalTrials.gov record NCT04572854
PeptideScanner retained ClinicalTrials.gov record NCT04572854 at 2026-11-16T01:37:14.654Z. Its registry update date was 2026-04-21, and PeptideScanner's reviewed identity mapping was pegcetacoplan.
- PeptideScanner change date
- November 16, 2026
- Cited source date
- April 21, 2026
- Evidence lane
- Clinical trials
ClinicalTrials.gov record NCT05067127
PeptideScanner retained ClinicalTrials.gov record NCT05067127 at 2026-11-16T01:37:14.654Z. Its registry update date was 2026-01-29, and PeptideScanner's reviewed identity mapping was pegcetacoplan.
- PeptideScanner change date
- November 16, 2026
- Cited source date
- January 29, 2026
- Evidence lane
- Clinical trials
ClinicalTrials.gov record NCT05809531
PeptideScanner retained ClinicalTrials.gov record NCT05809531 at 2026-11-16T01:37:14.654Z. Its registry update date was 2026-04-02, and PeptideScanner's reviewed identity mapping was pegcetacoplan.
- PeptideScanner change date
- November 16, 2026
- Cited source date
- April 2, 2026
- Evidence lane
- Clinical trials
Attributed registry records
Selected records
Pegcetacoplan · 2026-04-21
ClinicalTrials.gov record NCT04572854
Completed at the retained observation.
Open attributed record →Pegcetacoplan · 2026-04-02
ClinicalTrials.gov record NCT05809531
Active, not recruiting at the retained observation.
Open attributed record →Pegcetacoplan · 2026-01-29
ClinicalTrials.gov record NCT05067127
Completed at the retained observation.
Open attributed record →